RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
RT @JonathanNefro: FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSU…
FUROSEMIDA SUBCUTÁNEA genera la misma diuresis, pérdida de peso y eventos adversos; comparada con la INTRAVENOSA en INSUFICIENCIA CARDICA descompensada 💔, además de necesitar 50% menos dosis y se aplica fuera del hospital. JAm Coll Cardiol HF 2017; https:
Subcutaneous furosemide in the clinic. Comparison with high dose IV: "Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure" https://t.co/HmkBMsofGB
RT @DrMqAgMas: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatie…
RT @DrMqAgMas: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatie…
RT @DrMqAgMas: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatie…
RT @DrMqAgMas: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatie…
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure #GeribloC @SCGiG https://t.co/bNNfC2nTqA
RT @cholodelvado: Furosemida subcutánea (fórmula pH neutro) Para falla cardiaca Aún los estudios están en Fase II https://t.co/KvYh9vCPc9
This @JACCJournals study explores the efficacy & safety of a pH-neutral formulation of furosemide administered SC vs. IV for treatment of acute #HF. Read more: https://t.co/VG5zwPSxnQ https://t.co/tsiAioFCpy
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @accpcardprn: Subcutaneous furosemide for the outpatient treatment of heart failure with volume overload? New study in @JACCJournals Hea…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @FZores: Lasilix en sous-cut. Pourquoi pas. Plus simple en ville que l'IV, mais jusqu'à quelle dose ? Le pic plasmatique semble moins im…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
Another noninferiority trial, beloved by @VinayPrasad82 . Check the graph @ProfDFrancis . Funded by scPharmaceuticals. Nasdaq SCPH. https://t.co/FcvamsgrAc
The SC furosemide formulation looks promising. The depressing stat from this study was the ~50% risk of hospitalisation for these patients... even though those deemed at highest risk of hospitalisation had been excluded at the start! #heartfailure https://
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @RazaSN: Phase 2 trial of Subcutaneous vs. Intravenous Furosemide in outpatients with heart failure #JACCHF https://t.co/RwnWkWFxS3 HT @…
Lasilix en sous-cut. Pourquoi pas. Plus simple en ville que l'IV, mais jusqu'à quelle dose ? Le pic plasmatique semble moins important mais la durée plus longue qu'en IV (sorte de forme LP). Maniement à approfondir Intéressant https://t.co/csVVdg3XR9
Subcutaneous lasix in heart failure clinic patients. Interesting work by Gilotra and colleagues at Johns Hopkins. https://t.co/HAEhBIzkwz
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
RT @NirUrielMD: Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-i…
Great start to the week w/ our weekly HF journal club—from @JACCJournals on efficacy of Subq Lasix vs IV lasix. Small non-inferior trial demonstrating excellent bioavailability and efficacy of subq formulation which may be a key to ⬇️ HF readmissions https
RT @randreariba_rut: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Ou…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @RazaSN: Phase 2 trial of Subcutaneous vs. Intravenous Furosemide in outpatients with heart failure #JACCHF https://t.co/RwnWkWFxS3 HT @…
RT @cholodelvado: Furosemida subcutánea (fórmula pH neutro) Para falla cardiaca Aún los estudios están en Fase II https://t.co/KvYh9vCPc9
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @RazaSN: Phase 2 trial of Subcutaneous vs. Intravenous Furosemide in outpatients with heart failure #JACCHF https://t.co/RwnWkWFxS3 HT @…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
So this seems pretty awesome. @MathierMichael @mikegenuardi @PittCardiology https://t.co/r1w5UQw2zW
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @randreariba_rut: Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Ou…
Well this is certainly interesting! https://t.co/zTuXngSPVR
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure https://t.co/lrWNHe8WuO
Furosemida subcutánea (fórmula pH neutro) Para falla cardiaca Aún los estudios están en Fase II https://t.co/KvYh9vCPc9
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
Only useful if product is priced in a manner that most patients can afford. We are in an era where many pharmaceutical companies are abusing the trust of American people— just look at the asinine price of insulins and most other meds for diabetes as a cas
Bienvenida sea https://t.co/sYQSfjQUtF
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @Meraz2099: Subcutaneous furosemide!!! It works (apparently). Let’s see what happens. It shall work in other contexts, but, will it be b…
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
Subcutaneous furosemide!!! It works (apparently). Let’s see what happens. It shall work in other contexts, but, will it be better than bumetanide? #furosemide #diuretics #heartfailure https://t.co/gs81aj3cnu
Interesante https://t.co/bTKQlyYXK0
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…
RT @dompagano: This can be given at home. Better for the patient and for the healthcare. https://t.co/EZaDTT8xH4
RT @JACCJournals: Subcutaneous furosemide: could it change practice? @srusse14 Dr. Gary Francis provides his unique perspective in an accom…